申请人:Mead Johnson & Company
公开号:US04259482A1
公开(公告)日:1981-03-31
Styrylamidines are prepared by treating styrylsulfonylamidines with base. The styrylamidines are effective in the prevention of aggregation of blood platelets and as analgesics. Compounds of the invention are also useful as anticonvulsants, diuretics, and antihypertensive agents. The styrylsulfonylamidines of the invention which serve as precursors to the styrylamidines also have analgesic properties. Illustrative of the styrylamidines of the present invention are 4-amino-N-(4-aminostyryl)benzamidine and N-(3,4-dichlorostyryl)acetamidine. An example of a styrylsulfonylamidine is N-(styrylsulfonyl)acetamidine.
Styrylamidines是通过用碱处理styrylsulfonylamidines制备的。styrylamidines在预防血小板聚集和作为镇痛剂方面非常有效。本发明的化合物也可用作抗癫痫、利尿剂和降压剂。本发明的styrylsulfonylamidines作为styrylamidines的前体,也具有镇痛作用。本发明的styrylamidines的例子包括4-氨基-N-(4-氨基苯乙烯基)苯甲酰胺和N-(3,4-二氯苯乙烯基)乙酰胺。styrylsulfonylamidine的例子是N-(苯乙烯磺酰基)乙酰胺。